Sheridan Snyder, LLB (Hon) - Chairman and Chief Executive Officer, MolecularMD
Dick Brandewie - Managing Partner, Ballast Point Ventures
Chad Galderisi, D.O. - Vice President of Medical Affairs, MolecularMD
Frederick “Fritz” Eibel, Head of Commercial Operations, Genetic Analysis Division, Sequenom
Matt Rice, MBA - Principal, Ballast Point Ventures
Peter Maag, Ph.D. - President and Chief Executive Officer, XDx, Inc.
Dan Snyder, MBA - President and Chief Operating Officer, MolecularMD
Oncology Thought Leaders Series:
Brian Druker, MD speaks on the value of
companion diagnostics in patient outcomes
Companion Diagnostics Are Driving Support in the Evolving Regulatory Landscape
Companion diagnostics, necessary for safe and effective use of targeted cancer therapies,...
Read the full article here
Copyright 2013. All Rights Reserved